Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: The German AnaemIBD Study

Journal of Crohn's and Colitis

Volumn 8, Issue 10, 2014, Pages 1308-1314

  Blumenstein, Irina ^a   Dignass, Axel ^b,c   Vollmer, Stephan ^d   Klemm, Wolfgang ^e   Weber Mangal, Susanne ^f   Stein, Juergen ^b,g  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Crohn Colitis Center Rhein Main   (Germany)

^c AGAPLESION MARKUS KRANKENHAUS   (Germany)

^d Gastroenterological Practice   (Germany)

^e Gastroenterological Practice   (Germany)

^f Vifor (International) Inc   (Switzerland)

^g Hospital Sachsenhausen   (Germany)

Author keywords

Anaemia; Inflammatory bowel disease; Iron deficiency; Iron supplementation

Indexed keywords

ANTIANEMIC AGENT; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; IRON; STEROID; TRANSFERRIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERRITIN BLOOD LEVEL; GERMANY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON STORAGE; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT CARE; RETROSPECTIVE STUDY; SUPPLEMENTATION; TRANSFERRIN BLOOD LEVEL; TREATMENT DURATION; ULCERATIVE COLITIS; ADOLESCENT; ANEMIA; BLOOD; CLINICAL TRIAL; COMPLICATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD TRANSFUSION; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FERRITINS; GERMANY; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSFERRIN; YOUNG ADULT;

EID: 84908240451     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.03.010     Document Type: Article

References (30)

1. Stein J., Hartmann F., Dignass A.U. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010, 7:599-610.
2. Kulnigg S., Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006, 24:1507-1523.
3. Gisbert J.P., Bermejo F., Pajares R., Perez-Calle J.L., Rodriguez M., Algaba A., et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2009, 15:1485-1491.
4. Ott C., Liebold A., Takses A., Strauch U.G., Obermeier F. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract 2012, 2012:595970.
5. Wells C.W., Lewis S., Barton J.R., Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006, 12:123-130.
6. Stein J., Bager P., Befrits R., Danese S., Gasche C., Margo F., et al. Current European practice in diagnosis and treatment of IBD associated anaemia. J Crohns Colitis 2011, 5:S45-S46.
7. Voegtlin M., Vavricka S.R., Schoepfer A.M., Straumann A., Voegtlin J., Rogler G., et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis 2010, 4:642-648.
8. van Wyck D.B., Mangione A., Morrison J., Hadley P.E., Jehle J.A., Goodnough L.T. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009, 49:2719-2728.
9. Bager P., Befrits R., Wikman O., Lindgren S., Moum B., Hjortswang H., et al. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther 2012, 35:133-141.
10. Gasche C., Berstad A., Befrits R., Beglinger C., Dignass A., Erichsen K., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007, 13:1545-1553.
11. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study, Gastroenterology 1976, 70:439-444.
12. Walmsley R.S., Ayres R.C., Pounder R.E., Allan R.N. A simple clinical colitis activity index. Gut 1998, 43:29-32.
13. Blanc B., Finch C.A., Hallberg L., Herbert V., Lawkowicz W., Layrisse M., et al. Nutritional anaemias. Report of a WHO Scientific Group, WHO Tech Rep Ser 1968, 405:1-40.
14. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
15. Thomas C., Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol 2005, 11:14-23.
16. Bergamaschi G., Di Sabatino A., Albertini R., Ardizzone S., Biancheri P., Bonetti E., et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. nfluence of anti-tumor necrosis factor-alpha treatment. Haematologica 2010, 95:199-205.
17. National Heart L, and Blood Institute. The management of sickle cell disease 2002, National Institutes of Health, Bethesda, MD, [NIH publication 02-2117]. 4th ed.
18. Wish J.B. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006, 1(Suppl. 1):S4-S8.
19. Pels L.P., Van de Vijver E., Waalkens H.J., Uitentuis J., Gonera-de Jong G., van Overbeek L.A., et al. Slow hematological recovery in children with IBD-associated anemia in cases of "expectant management". J Pediatr Gastroenterol Nutr 2010, 51:708-713.
20. Weinstock L.B., Bosworth B.P., Scherl E.J., Li E., Iroku U., Munsell M.A., et al. Crohn's disease is associated with restless legs syndrome. Inflamm Bowel Dis 2010, 16:275-279.
21. Cronin C.C., Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol 2001, 96:2296-2298.
22. Gisbert J.P., Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008, 103:1299-1307.
23. Schroder O., Mickisch O., Seidler U., de Weerth A., Dignass A., Herfarth H., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005, 100:2503-2509.
24. Kulnigg S., Stoinov S., Simanenkov V., Dudar L.V., Karnafel W., Garcia L.C., et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008, 103:1182-1192.
25. Lindgren S., Wikman O., Befrits R., Blom H., Eriksson A., Granno C., et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009, 44:838-845.
26. Van Assche G., Dignass A., Bokemeyer B., Danese S., Gionchetti P., Moser G., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013, 7:1-33.
27. Mowat C., Cole A., Windsor A., Ahmad T., Arnott I., Driscoll R., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011, 60:571-607.
28. Vavricka S.R., Schoepfer A.M., Safroneeva E., Rogler G., Schwenkglenks M., Achermann R. A shift from oral to intravenous iron supplementation therapy is observed over time in a large Swiss cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis 2013, 19:840-846.
29. Vamvakas E.C., Blajchman M.A. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009, 113:3406-3417.
30. Spahn D.R., Moch H., Hofmann A., Isbister J.P. Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology 2008, 109:951-953.